ketanserin has been researched along with Vasculitis in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rustin, MH | 1 |
| Bunker, CB | 1 |
| Dowd, PM | 1 |
1 other study available for ketanserin and Vasculitis
| Article | Year |
|---|---|
Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin.
Topics: Administration, Oral; Chronic Disease; Female; Humans; Ketanserin; Leg Ulcer; Middle Aged; Raynaud D | 1989 |